Bromosulfophthalein half-time elimination test in children with chronic liver disease after single intravenous administration of the dye
Votruba, M.; Cihula, J.; Sakarová, V.
Ceskoslovenska Pediatrie 31(7): 405-408
1976
ISSN/ISBN: 0069-2328 PMID: 963830 Document Number: 106097
Document emailed within 1 workday
Related Documents
Müting, D.; Dohn, P.; Reikowski, J. 1972: Effect of high-dose, intravenous and oral administration of essential phospholipids on protein and lipid metabolism as well as enzyme activities in patients with chronic liver disease Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 1389-1392Kupcová, V.; Turecký, L.; Brixová, E. 1992: Determination of galactose eliminating capacity after intravenous administration--a liver function test Vnitrni Lekarstvi 38(10): 992-999
Chiarioni, T. 1970: Synthetic evaluation of the result of the curve of aminoacidemia after intravenous administration of glycine as a liver function test Minerva Medica 61(85): 4759-4764
Klapdor, R.; Eppers, J. 1974: Multicompartmental analysis of 2- and 3 exponential plasma disapperance curves following single I.v. injection of C14-cholic acid, bromosulfophthalein and 14C-bilirubin and their importance for quantitative studies of the excretory liver function Zeitschrift für Gastroenterologie 12(1): 1-8
Steinberg, M.; Marner I-L; Rasmussen, J.W. 1974: Hepatography patterns following rectal administration of radioiodine as seen in chronic liver disease and other liver disorders Scandinavian Journal of Gastroenterology 9(1): 73-79
Liot, F.; Lemaigre, D.; Haddad, J.; Solvignon, F. 1975: Action of acebutolol on heart rate and FEV1 in asthmatic patients. Single intravenous administration and long term oral administration La Nouvelle Presse Medicale 4(46 Suppl): 3259-3262
Bukhtiari, N.; Hussain, T.; Iqbal, M.; Malik, A.M.; Qureshi, A.H.; Hussain, A. 2003: Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern Jpma. Journal of the Pakistan Medical Association 53(4): 136-140
Hayes, P.C.; Bouchier, I.A. 1989: Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease American Journal of Gastroenterology 84(7): 723-726
Skrinska, V.A.; Lucas, F.V.; Chisolm, G.M.; Hesse, B.L. 1986: Intravenous administration of prostacyclin in rabbits: elimination kinetics and blood pressure response Journal of Laboratory and Clinical Medicine 107(3): 187-193
Marzo, A.; Ghirardi, P.; Maggi, G.C.; Piscitello, F.; Gobetti, F.; Marchetti, G. 1974: Plasma levels and urinary elimination of k-strophanthoside in intravenous administration in patients with renal insufficiency Bollettino della Societa Italiana di Biologia Sperimentale 50(19): 1594-1597
Piotrovskiĭ, V.K.; Merkulova, I.N.; Romina, N.N.; Metelitsa, V.I. 1982: Ethmozin pharmacokinetics after a single intravenous administration Kardiologiia 22(5): 75-80
Högler, W.; Baumann, U.; Kelly, D. 2010: Growth and bone health in chronic liver disease and following liver transplantation in children Pediatric Endocrinology Reviews: Per 7(3): 266-274
Lejeune, P.; Desager, J.P.; Meunier, H.; Harvengt, C. 1988: Kinetics of a single dose combination of nifedipine/acebutolol in patients with chronic liver disease International Journal of Clinical Pharmacology Therapy and Toxicology 26(10): 513-516
Cone, E.J.; Risner, M.E.; Neidert, G.L. 1978: Concentrations of phenethylamine in dog following single doses and during intravenous self-administration Research Communications in Chemical Pathology and Pharmacology 22(2): 211-232
Pryzjemski, J.; Wlasiuk, M.; Chrostowska, H. 1976: Assessment of the gluconeogenetic function of the liver on the basis of blood lactate elimination in patients with acute and chronic liver damage Przeglad Lekarski 33(12): 979-983
Vogten, A.J.; Hadzic, N.; Shorter, R.G.; Summerskill, W.H.; Taylor, W.F. 1978: Cell-mediated cytotoxicity in chronic active liver disease: a new test system Gastroenterology 74(5 Part 1): 883-889
Bichler, J.; Fichtl, B.; Siebeck, M.; Fritz, H. 1988: Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration Arzneimittel-Forschung 38(5): 704-710
Shugushev, K.K.; Gneushev, E.T.; Smetnev, A.S.; Kukes, V.G.; Rozenshtraukh, L.V. 1985: Comparison of the results of ethacizin pharmacodynamics and pharmacokinetics in a single intravenous administration Kardiologiia 25(4): 32-35
Bagli, M.; Rao, M.L.; Höflich, G.; Kasper, S.; Langer, M.; Barlage, U.; Beneke, M.; Süverkrüp, R.; Möller, H.J. 1996: Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations Arzneimittel-Forschung 46(3): 247-250
Biffl, H.; Goebel, R.; Leb, G. 1979: The clinical significance of radioimmunologically determined serum bile acids as a new liver function test and the development of a new intravenous sulfolithoglycocholic acid (SLGC) stimulation test Acta Medica Austriaca 6(4): 113-120